PL377706A1 - Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania - Google Patents

Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania

Info

Publication number
PL377706A1
PL377706A1 PL377706A PL37770604A PL377706A1 PL 377706 A1 PL377706 A1 PL 377706A1 PL 377706 A PL377706 A PL 377706A PL 37770604 A PL37770604 A PL 37770604A PL 377706 A1 PL377706 A1 PL 377706A1
Authority
PL
Poland
Prior art keywords
esters
salts
preparation
pharmaceutical composition
alendronic acid
Prior art date
Application number
PL377706A
Other languages
English (en)
Inventor
Miha Tomaz Jaklic
Vlasta Humar
Helena Suklje-Debeljak
Judita Sirca
Milojka Mohar
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of PL377706A1 publication Critical patent/PL377706A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL377706A 2003-02-27 2004-02-26 Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania PL377706A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300052A SI21403A (sl) 2003-02-27 2003-02-27 Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo

Publications (1)

Publication Number Publication Date
PL377706A1 true PL377706A1 (pl) 2006-02-06

Family

ID=32906916

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377706A PL377706A1 (pl) 2003-02-27 2004-02-26 Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania

Country Status (8)

Country Link
EP (1) EP1599191B1 (pl)
AT (1) ATE464884T1 (pl)
CA (1) CA2517372C (pl)
DE (1) DE602004026689D1 (pl)
EA (1) EA009333B1 (pl)
PL (1) PL377706A1 (pl)
SI (1) SI21403A (pl)
WO (1) WO2004075828A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006018033A1 (en) * 2004-08-20 2006-02-23 Mepha Ag Formulations of bisphosphonates
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
WO2009018834A1 (en) * 2007-08-06 2009-02-12 Pharmathen S.A. Pharmaceutical composition containing bisphosphonate and method for the preparation thereof
CN107252419A (zh) * 2010-12-22 2017-10-17 巴斯夫欧洲公司 快速崩解的固体包衣剂型
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
CN116211818B (zh) * 2023-03-10 2024-04-09 菲洋生物科技(吉林)有限公司 一种含有阿仑膦酸钠的片剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121623A (en) * 1997-08-26 2000-06-29 Unipharm Ltd Process for the preparation of solid oral dosage forms comprising alendronic acid
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AU1195001A (en) * 1999-10-11 2001-04-23 Monsanto Company Tablets coated with locust bean gum, guar gum or carrageenan gum
US6476006B2 (en) * 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

Also Published As

Publication number Publication date
CA2517372C (en) 2012-07-17
WO2004075828A2 (en) 2004-09-10
EA009333B1 (ru) 2007-12-28
WO2004075828A3 (en) 2004-10-28
EP1599191B1 (en) 2010-04-21
EA200501221A1 (ru) 2006-04-28
DE602004026689D1 (de) 2010-06-02
ATE464884T1 (de) 2010-05-15
EP1599191A2 (en) 2005-11-30
SI21403A (sl) 2004-08-31
CA2517372A1 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
SG116575A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutical acceptable acid.
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
MXPA04003636A (es) Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato.
WO2008022932A3 (en) Controlled release system and method for manufacturing the same
WO2010078486A3 (en) Opioid-containing oral pharmaceutical compositions and methods
MX2010003439A (es) Combinacion farmaceutica de aliskiren y valsartan.
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
MX2010004323A (es) Formas de dosificacion oral que comprenden acetato de licarbazepina.
IL175127A0 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
EP2586427A3 (en) Balsalazide formulations and manufacture thereof
BG108516A (en) Pharmaceutical formulation
MXPA03007087A (es) Procedimiento para fabricacion de derivados de acido fenilacetico.
WO2009045795A3 (en) Galenical formulations of aliskiren and valsartan
WO2007021968A3 (en) Sustained release antihistamine and decongestant composition
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
PL377706A1 (pl) Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania
IL192190A0 (en) Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
MY144613A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same
ATE409463T1 (de) Oral dispergierbare pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
SG148120A1 (en) An oral pharmaceutical and an oral care product
JO3239B1 (ar) تركيبات جالينية من مركبات عضوية
MX2009005804A (es) Composicion farmaceutica de memantina.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)